Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Targets high-growth eye care expansion push
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
One task, one interaction, one pair, experts advocate
Subscribe To Our Newsletter & Stay Updated